Advertisement
Advertisement

CARL

C

Carlsmed, Inc. Common Stock

11.71
USD
Sponsored
+0.42
+3.68%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

11.71

0.00
0.00%

CARL Earnings Reports

Positive Surprise Ratio

CARL beat 1 of 1 last estimates.

100%

Next Report

Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$14.79M
/
-$0.43
Implied change from Q3 25 (Revenue/ EPS)
+13.14%
/
+7.50%
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

Carlsmed, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, CARL reported earnings of -0.40 USD per share (EPS) for Q3 25, beating the estimate of -0.46 USD, resulting in a 13.63% surprise. Revenue reached 13.07 million, compared to an expected 11.63 million, with a 12.46% difference. The market reacted with a +14.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.43 USD, with revenue projected to reach 14.79 million USD, implying an increase of 7.50% EPS, and increase of 13.14% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
logo
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
logo
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
FAQ
For Q3 2025, Carlsmed, Inc. Common Stock reported EPS of -$0.40, beating estimates by 13.63%, and revenue of $13.07M, 12.46% above expectations.
The stock price moved up 14.89%, changed from $11.89 before the earnings release to $13.66 the day after.
The next earning report is scheduled for Feb 19, 2026.
Based on -- analysts, Carlsmed, Inc. Common Stock is expected to report EPS of -$0.43 and revenue of $14.79M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement